AMEX:MLSS

Stock Analysis Report

Executive Summary

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally.

Snowflake

Fundamentals

High growth potential with mediocre balance sheet.

Share Price & News

How has Milestone Scientific's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MLSS's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0.9%

MLSS

1.8%

US Medical Equipment

0.5%

US Market


1 Year Return

89.5%

MLSS

23.3%

US Medical Equipment

16.1%

US Market

Return vs Industry: MLSS exceeded the US Medical Equipment industry which returned 23.3% over the past year.

Return vs Market: MLSS exceeded the US Market which returned 16.1% over the past year.


Shareholder returns

MLSSIndustryMarket
7 Day0.9%1.8%0.5%
30 Day-15.6%4.3%3.9%
90 Day64.4%2.8%6.6%
1 Year89.5%89.5%24.3%23.3%18.7%16.1%
3 Year-36.5%-36.5%88.6%82.9%47.2%37.7%
5 Year-50.5%-50.5%116.3%92.9%61.5%43.7%

Price Volatility Vs. Market

How volatile is Milestone Scientific's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Milestone Scientific undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Milestone Scientific is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Milestone Scientific has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

Future Growth

How is Milestone Scientific forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

92.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MLSS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.7%).

Earnings vs Market: MLSS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MLSS's is expected to become profitable in the next 3 years.

Revenue vs Market: MLSS's revenue (28.1% per year) is forecast to grow faster than the US market (7.3% per year).

High Growth Revenue: MLSS's revenue (28.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MLSS's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Milestone Scientific performed over the past 5 years?

-17.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MLSS has high quality earnings.

Growing Profit Margin: MLSS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: MLSS is unprofitable, and losses have increased over the past 5 years at a rate of -17.3% per year.

Accelerating Growth: Unable to compare MLSS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MLSS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.3%).


Return on Equity

High ROE: MLSS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Milestone Scientific's financial position?


Financial Position Analysis

Short Term Liabilities: MLSS has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: MLSS has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: MLSS is debt free.

Reducing Debt: MLSS's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: MLSS has a high level of physical assets or inventory.

Debt Coverage by Assets: MLSS has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MLSS has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MLSS has sufficient cash runway for 1.213828 years if free cash flow continues to grow at historical rates of 55.2% each year.


Next Steps

Dividend

What is Milestone Scientific's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate MLSS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate MLSS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MLSS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MLSS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MLSS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Milestone Scientific's salary, the management and board of directors tenure and is there insider trading?

3.1yrs

Average management tenure


CEO

Leonard Osser (72yo)

1.9yrs

Tenure

US$540,484

Compensation

Mr. Leonard A. Osser has been the Interim Chief Executive Officer of Milestone Scientific Inc., since December 18, 2017. Mr. Osser is a Founder of Milestone Scientific Inc. and had been Managing Director o ...


CEO Compensation Analysis

Compensation vs Market: Leonard's total compensation ($USD540.48K) is about average for companies of similar size in the US market ($USD504.52K).

Compensation vs Earnings: Leonard's compensation has been consistent with company performance over the past year.


Management Age and Tenure

3.1yrs

Average Tenure

59yo

Average Age

Experienced Management: MLSS's management team is considered experienced (3.1 years average tenure).


Board Age and Tenure

4.6yrs

Average Tenure

65yo

Average Age

Experienced Board: MLSS's board of directors are considered experienced (4.6 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$250,00026 Feb 19
Innovest SpA
EntityCompany
Shares714,286
Max PriceUS$0.35
BuyUS$29,75026 Feb 19
Michael McGeehan
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares85,000
Max PriceUS$0.35
BuyUS$99,75008 Feb 19
Leonard Osser
EntityIndividual
Role
Chief Executive Officer
Founder
Shares285,000
Max PriceUS$0.35
BuyUS$5,25008 Feb 19
Edward Zelnick
EntityIndividual
Shares15,000
Max PriceUS$0.35

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.7%.


Management Team

  • Leonard Osser (72yo)

    Founder

    • Tenure: 1.9yrs
    • Compensation: US$540.48k
  • Rosaline Shau (59yo)

    Vice President and Assistant Controller

    • Tenure: 0yrs
  • Joseph D'Agostino (67yo)

    CFO & COO

    • Tenure: 11.8yrs
    • Compensation: US$225.30k
  • Brent Johnston (50yo)

    President

    • Tenure: 0.2yrs
  • Gian Trombetta (58yo)

    Director and President & CEO of Wand Dental Inc.

    • Tenure: 5.5yrs
    • Compensation: US$280.00k
  • James McAvinn

    Senior Vice President of Sales & Marketing

    • Tenure: 3.1yrs

Board Members

  • Leslie Bernhard (75yo)

    Independent Chairman of the Board

    • Tenure: 10.1yrs
    • Compensation: US$66.00k
  • Leonard Osser (72yo)

    Founder

    • Tenure: 1.9yrs
    • Compensation: US$540.48k
  • Neal Goldman (75yo)

    Independent Director

    • Tenure: 0.6yrs
  • Leonard Schiller (78yo)

    Independent Director

    • Tenure: 22.6yrs
    • Compensation: US$36.00k
  • Zhang Lidong (58yo)

    Member of Global Advisory Board

    • Tenure: 3.7yrs
  • Joe Chalil (46yo)

    Member of Global Advisory Board

    • Tenure: 3.7yrs
  • Gian Trombetta (58yo)

    Director and President & CEO of Wand Dental Inc.

    • Tenure: 5.5yrs
    • Compensation: US$280.00k
  • Michael McGeehan (53yo)

    Independent Director

    • Tenure: 2.1yrs
    • Compensation: US$36.00k

Company Information

Milestone Scientific Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Milestone Scientific Inc.
  • Ticker: MLSS
  • Exchange: AMEX
  • Founded: 1989
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$52.796m
  • Shares outstanding: 48.88m
  • Website: https://www.milestonescientific.com

Number of Employees


Location

  • Milestone Scientific Inc.
  • 220 South Orange Avenue
  • Livingston
  • New Jersey
  • 7039
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MLSSAMEX (NYSE MKT LLC)YesCommon StockUSUSDNov 1995

Biography

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/20 23:42
End of Day Share Price2019/11/20 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.